We believe that the following are our primary competitive strengths:

1. Strong culture for research and innovation.

We are a research driven company with our R&D efforts focused on developing new formulations, both in the allopathic and herbal segment. Our Company has set up a Research & Development centre at Shantinagar, Nagpur. Our R&D facility comprises of research and analytical laboratories at Shantinagar, Nagpur with a team of 20 R&D personnel as on July 31, 2010, with expertise in the development of new dosage forms, NDDS and specialized formulations. As of July 31, 2010, we employed 4 scientists and specialists for our R&D activities. We have the R&D capability and experience to develop, manufacture and register products across various formulations, dosage forms and delivery systems to increase the effectiveness of drugs and make our products better suited to market requirements. Our regulatory affairs team has also developed capabilities and processes to file product registrations in semi-regulated markets and as on July 31, 2010, and has filed over 25 applications worldwide.

2. Expertise in complex allopathic and herbal formulations.

We believe our expertise in developing complex and difficult to develop products such as converting suspensions in syrup form and complex and difficult to develop delivery systems, such as coating of herbal extracts on pellets provides us with a competitive advantage. We believe we were one of first companies’ in India to have developed a pellet technology system for ‘PELLETS OF HERBAL EXTRACTS AND THE PROCESS OF PREPARING PELLETS’ which provides us with a early mover advantage. In the year 2006, 2007 and 2010, we have filed three (3) patent applications with WIPO for registration of (i) ‘PELLETS OF HERBAL EXTRACTS AND THE PROCESS OF PREPARING PELLETS’; (ii) ‘HERBAL GASTROINTENSTINAL CONTROLLED DRUG DELIVERY DOSAGE FORMS INCLUDING PELLETS AND PROCESS FOR THEIR PREPARATION’; and (iii) ‘RAPID DISSOLVABLE ORAL FILM FOR DELIVERING HERBAL EXTRACTS WITH OR WITHOUT OTHER PHARMACEUTICAL AGENTS’, respectively. Further, our Company has also a National Phase Application in Malaysia for registration of ‘PELLETS OF HERBAL EXTRACTS AND THE PROCESS OF PREPARING PELLETS’. Further, our Company has filed separate patent applications for the above inventions with the Patent Office, Mumbai. Some of our products are complex formulations developed by using knowledge and expertise gained across the allopathic and herbal segments of the pharmaceuticals industry.

3. Diversified business model.

Our Company is a pharmaceutical company primarily into the business of manufacturing and marketing of branded and non-branded allopathic and herbal formulations for human and veterinary consumption. Our Company also has presence in the beauty care segment based on herbals which is a natural extension of our herbal formulations business. Our Company has presence and derives income from various verticals of pharmaceutical industry. Our diversified business model reduces our cost of operations and apart from enabling us to exchange experience and knowledge gained in operating these business verticals also enable us to control input costs and thereby increase our margins.

4. Exchange of experience and knowledge between different systems of medicines and business verticals.

Since, the end objective of all systems of medicines is the cure of diseases and we as a Company are into the development of medicines in three (3) known systems of medicines viz. allopathy, herbal and ayurveda, this diversity of knowledge and sharing information between different systems of medicine gives us an edge over pure allopathy or herbal based pharmaceutical companies. For example using modern manufacturing techniques developed through allopathic WHO cGMP practices has enabled us to manufacture herbal products without microbial contamination. Our huge knowledge base and experience in traditional Ayurveda enables us to ensure that our herbal products keep their effectiveness while being more palletable. Also, this knowledge base of herbal plants enables us to identify starter compounds for further development into new therapeutic drugs reducing the chances of failures considerably.

We continuously endeavor to enhance the effectiveness of FDFs after understanding the difficulties or side effects faced by the consumer. The feedback from the consumer and doctors is then used by our R&D to undertake processes whereby a value-add can be provided to the existing product in order to reduce the known difficulties or side effects. For example, readily available pain killers like “ibuprofen” and “paracetamol” which are in suspension form leave a very bitter after taste in the mouth. We have created a FDF namely “Polygesic” which is a clear liquid with no after taste.

5. Experienced and qualified management and executives.

Our team includes senior executives, a majority of whom have over 14 years experience in the pharmaceutical industry. We believe our management and executive team has a long-term vision and provides stability and continuity to our business. We also believe that the understanding and expertise of our management and executive team in R&D, regulatory affairs, manufacturing, finance, sales and marketing will enable our business to grow in a focused and constructive manner. As of July 31, 2010, approximately 31 of our employees were post-graduates and 128 held graduate degrees.